A novel event-free survival endpoint in locally advanced pancreatic cancer

The treatment paradigm for locally advanced pancreatic cancer (LAPC) is evolving rapidly. The development of neoadjuvant therapies composed of combination therapies and the evaluation of their impact on conversion to borderline resectable (BR) status, resection, and ultimately overall survival (OS)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pascal Hammel, Ewa Carrier, Mairead Carney, Mark Eisner, Thomas Fleming
Formato: article
Lenguaje:EN
Publicado: SAGE Publishing 2021
Materias:
Acceso en línea:https://doaj.org/article/40c80974de284a6c9e33fe3074c7496e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!